Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a Living Related Renal Transplant Recipient

American Journal of Kidney Diseases

Volumn 53, Issue 2, 2009, Pages 321-326

  Chan, Micah R ^a   Thomas, Christie P ^b   Torrealba, Jose R ^c   Djamali, Arjang ^a   Fernandez, Luis A ^a   Nishimura, Carla J ^d   Smith, Richard J H ^b,d   Samaniego, Millie D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of Wisconsin Health   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

factor I; hemolytic uremic syndrome (HUS); Kidney transplant; recurrent

Indexed keywords

ALEMTUZUMAB; CD4 ANTIGEN; DEXAMETHASONE; FIBRINOGEN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RITUXIMAB; SERINE; TACROLIMUS; TYROSINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHROMATOGRAPHY; CLINICAL FEATURE; FECES CULTURE; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY GRAFT; LABORATORY TEST; MISSENSE MUTATION; NEPHRECTOMY; PLASMAPHERESIS; URINALYSIS;

ADULT; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MUTATION, MISSENSE; RECURRENCE;

EID: 58249107188     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.06.027     Document Type: Article

References (27)

1. Gasser C., Gautier E., Steck A., Siebenmann R.E., and Oechslin R. Hemolytic-uremic syndrome: Bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr 85 (1955) 905-909
2. Atkinson J.P., Liszewski M.K., Richards A., Kavanagh D., and Moulton E.A. Hemolytic uremic syndrome. An example of insufficient complement regulation on self-tissue. Ann N Y Acad Sci 1056 (2005) 144-152
3. Kavanagh D., Goodship T.H., and Richards A. Atypical haemolytic uraemic syndrome. Br Med Bull 77-78 (2006) 5-22
4. Kavanagh D., Richards A., and Atkinson J. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59 (2008) 293-309
5. Goicoechea de Jorge E., Harris C.L., Esparza-Gordillo J., et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A 104 (2007) 240-245
6. Jokiranta T.S., Zipfel P.F., Fremeaux-Bacchi V., Taylor C.M., Goodship T.J., and Noris M. Where next with atypical hemolytic uremic syndrome?. Mol Immunol 44 (2007) 3889-3900
7. Bresin E., Daina E., Noris M., et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated haemolytic syndrome: Prognostic significance of genetic background. Clin J Am Soc Nephrol 1 (2006) 88-99
8. Kavanagh D., and Goodship T.H. Membrane cofactor protein and factor I: Mutations and transplantation. Semin Thromb Hemost 32 (2006) 155-159
9. Sellier-Leclerc A.L., Fremeaux-Bacchi V., Dragon-Durey M.A., et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18 (2007) 2392-2400
10. Artz M.A., Steenbergen E.J., Hoitsma A.J., Monnens L.A., and Wetzels J.F. Renal transplantation in patients with hemolytic uremic syndrome: High rate of recurrence and increased incidence of acute rejections. Transplantation 76 (2003) 821-826
11. Remuzzi G., Ruggenenti P., Colledan M., et al. Hemolytic uremic syndrome: A fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am J Transplant 5 (2005) 1146-1150
12. Ponticelli C., and Banfi G. Thrombotic microangiopathy after kidney transplantation. Transpl Int 19 (2006) 789-794
13. Alper C.A., Abramson N., Johnston Jr. R.B., Jandl J.H., and Rosen F.S. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N Engl J Med 282 (1970) 350-354
14. Geelen J., van den Dries K., Roos A., et al. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome. Pediatr Nephrol 22 (2007) 371-375
15. Nilsson S.C., Karpman D., Vaziri-Sani F., et al. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Mol Immunol 44 (2007) 1835-1844
16. Kavanagh D., and Goodship T.H. Update on evaluating complement in hemolytic uremic syndrome. Curr Opin Nephrol Hypertens 16 (2007) 565-571
17. Kavanagh D., Richards A., Noris M., et al. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol 45 (2008) 95-105
18. Warwicker P., Goodship T.H., Donne R.L., et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53 (1998) 836-844
19. Dragon-Durey M.A., Loirat C., Cloarec S., et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 16 (2005) 555-563
20. Donne R.L., Abbs I., Barany P., et al. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am J Kidney Dis 40 (2002) 1-4
21. Conlon P.J., Brennan D.C., Pfaf W.W., et al. Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. Nephrol Dial Transplant 11 (1996) 1810-1814
22. Ducloux D., Rebibou J.M., SemhounDucloux S., et al. Recurrence of hemolytic-uremic syndrome in renal transplant recipients-A meta-analysis. Transplantation 65 (1998) 1405-1407
23. Lahlou A., Lang P., Charpentier B., et al. Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF). Medicine 79 (2000) 90-102
24. Quan A., Sullivan E.K., and Alexander S.R. Recurrence of hemolytic uremic syndrome after renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 72 (2001) 742-745
25. Kavanagh D., Richards A., Fremeaux-Bacchi V., et al. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2 (2007) 591-596
26. Saland J.M., Emre S.H., Shneider B.L., et al. Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 6 (2006) 1948-1952
27. Jalanko H., Peltonen S., Koskinen A., et al. Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant 8 (2008) 216-221